Ground-breaking Weight Management Study
Our researchers are currently involved in a clinical trial named DiRECT (Diabetes Remission Clinical Trial) with the goal of achieving remission in type 2 diabetes.
Insulin-Producing Beta Cell Research
The focus of our studies is on preserving insulin-producing beta cells in type 1 diabetes and developing treatments to prevent the immune system from attacking these cells.
Call for Donations
We rely on your support to propel our research forward in the quest for a diabetes cure. Your donations can make a real difference in the lives of those affected by this disease.
This article was received on May 29, 2015, revised on June 28, 2015, accepted on July 6, 2015, and collection date was in 2015.
It falls under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License. This means that you are free to share and adapt the article for non-commercial purposes, as long as you give appropriate credit to the original author.
Complete Remission of Type 1 Diabetes
Instances of complete remission in type 1 diabetes cases are rare, with varying durations and influencing factors.
Complete remission in type 1 diabetes refers to a period of time where an individual no longer requires insulin injections to maintain normal blood sugar levels. This can occur spontaneously or as a result of certain treatments or therapies.
Factors that may influence the likelihood of achieving complete remission include early diagnosis, strict adherence to treatment plans, genetic predisposition, and overall lifestyle choices such as diet and exercise. Research into the mechanisms of type 1 diabetes and potential cures continues to evolve, offering hope for more effective treatments and eventually, a permanent cure for the condition.
Additional Information on Type 1 Diabetes Diagnosis
In addition to the criteria mentioned earlier, other factors that may indicate type 1 diabetes include symptoms such as frequent urination, increased thirst, unexplained weight loss, fatigue, and blurred vision. It is important for healthcare providers to conduct thorough physical examinations and blood tests to accurately diagnose type 1 diabetes. Early detection and management of the condition are crucial in preventing complications and promoting better health outcomes for individuals with type 1 diabetes.
Patient Case Study
A 32-year-old woman newly diagnosed with type 1 diabetes achieved complete remission following a period of insulin therapy and subsequent non-compliance.
After achieving remission, the patient was advised to follow a strict diet and exercise regimen to manage her diabetes. However, she struggled to adhere to the recommended lifestyle changes and frequently skipped her insulin injections.
Despite her non-compliance, the patient continued to monitor her blood sugar levels regularly and reported occasional episodes of hyperglycemia. She also experienced symptoms of fatigue and increased thirst, which she attributed to stress from work and personal life.
Medical professionals worked closely with the patient to address her concerns and develop a more manageable diabetes management plan. Through education, counseling, and support, the patient was able to gradually improve her adherence to insulin therapy and make healthier lifestyle choices.
With ongoing support and guidance, the patient was able to successfully control her diabetes and maintain stable blood sugar levels. This case study highlights the importance of patient education, support, and personalized care in managing type 1 diabetes and achieving long-term remission.
Clinical Presentation
Complete remission is more frequent in adults compared to children, with rates ranging from 3-61% in newly diagnosed adult cases. Certain factors like higher BMI, normal bicarbonate levels, and mild hyperglycemia are linked to increased remission rates.
In children, partial remission is more common (25-100%) than complete remission. Most studies indicate peak remission levels 3 months post-diagnosis, with onset age not consistently correlating with remission rates.
Intensive insulin management may enhance remission rates in new-onset type 1 diabetes patients. Ongoing research explores immune-modulator interventions to prevent or reverse the condition, although no universal treatment has been identified.
Conclusion
Complete remission of type 1 diabetes, especially in children, is uncommon. Research is underway to improve beta cell function in recently diagnosed cases, but no single approach is universally recommended.
Acknowledgements
The Research Open Access Article Publishing (ROAAP) Fund at the University of Illinois at Chicago supported this article financially. The authors declare no conflicts of interest, grant support, or financial disclosures.
Conflict of interest and funding
Current investigations aim to enhance understanding of type 1 diabetes pathophysiology and management to elevate remission rates.
We would like to thank the University of Illinois at Chicago for their financial support through the ROAAP fund. This support was crucial in conducting the research and publishing this article.
The authors would also like to express their gratitude to all individuals and organizations who have contributed to the advancement of type 1 diabetes research. Without their support and dedication, progress in understanding the pathophysiology and management of the disease would not have been possible.
References
- Diverse studies examine remission rates in type 1 diabetes patients using various management techniques.
- Studies on immune-modulators and immunosuppressive agents are ongoing to potentially alter type 1 diabetes progression.
- Details of individual study outcomes concerning these interventions are extensive and beyond this review article’s scope.
- Couper JJ, Hudson I, Werther G, Warne G, Court J, Harrison L. Predictive factors for residual beta-cell function in the initial year after the diagnosis of type 1 diabetes in children. Published in Diabetes Research and Clinical Practice in 1991;11:9–16. doi: 10.1016/0168-8227(91)90135-z. [PubMed] [Google Scholar]
- Knip M, Sakkinen A, Huttenen N, Kär ML, Länkel S, Mustonen A, et al. Analysis of 178 cases of postinitial remission in diabetic children. Published in Acta Paediatrica Scandinavica in 1982;71:901–8. doi: 10.1111/j.1651-2227.1982.tb09546.x. [PubMed] [Google Scholar]
- Madsbad S, Krarup T, Reguer L, Faber OK, Binder C. Impact of tight blood glucose control on residual beta-cell function in individuals with insulin-dependent diabetes. Published in Diabetologia in 1981;20:530–4. doi: 10.1007/BF00252760. [PubMed] [Google Scholar]
- Shah SC, Malone JI, Simpson NE. Examination of intensive insulin therapy in newly diagnosed cases of insulin-dependent diabetes mellitus through a randomized trial. Published in the New England Journal of Medicine in 1989;320:550–4. doi: 10.1056/NEJM198903023200902. [PubMed] [Google]
- Perlman K, Ehrlich RM, Filler RM, Albisser AM. Maintenance of normal blood sugar levels in recently diagnosed type 1 diabetic individuals. Published in Diabetes in 1984;33:995–1001. doi: 10.2337/diab.33.10.995. [PubMed] [Google]
- Rewers M, Gottlieb P. Overview of immunotherapy for the prevention and treatment of type 1 diabetes, including current human trials and future prospects. Published in Diabetes Care in 2009;32:1769–82. doi: 10.2337/dc09-0374. [PMC free article] [PubMed] [Google]
With permission from Greater Baltimore Medical Center, the above articles are sourced from the Journal of Community Hospital Internal Medicine Perspectives.